Salt Substitution and Recurrent Stroke and Death: A Randomized Clinical Trial
- PMID: 39908026
- PMCID: PMC11800127
- DOI: 10.1001/jamacardio.2024.5417
Salt Substitution and Recurrent Stroke and Death: A Randomized Clinical Trial
Abstract
Importance: The direct effect of consumption of salt substitutes on recurrent stroke and mortality among patients with stroke remains unclear.
Objective: To evaluate the effects of salt substitutes vs regular salt on the incidence of recurrent stroke and mortality among patients with stroke.
Design, setting, and participants: The Salt Substitute and Stroke Study (SSaSS), an open-label, cluster randomized clinical trial, was conducted in 600 northern Chinese villages (clusters). Patients who self-reported a hospital diagnosis of stroke were included in this prespecified subgroup analysis. Data were analyzed from November 2023 to August 2024.
Interventions: Participants were assigned to use either a salt substitute, consisting of 75% sodium chloride and 25% potassium chloride by mass, or regular salt.
Main outcomes and measures: The primary outcome was recurrent stroke.
Results: After excluding 5746 persons without a baseline history of stroke, 15 249 patients with stroke (mean [SD] age, 64.1 [8.8] years; 6999 [45.9%] female; 8250 male [54.1%]) were included. Over a median (IQR) follow-up of 61.2 (60.9-61.6) months, the mean difference in systolic blood pressure was -2.05 mm Hg (95% CI, -3.03 to -1.08 mm Hg). A total of 2735 recurrent stroke events (691 fatal and 2044 nonfatal) and 3242 deaths were recorded. Recurrent stroke was significantly lower in the salt substitute vs regular salt group (rate ratio [RR], 0.86; 95% CI, 0.77-0.95; P = .005), with larger effects on hemorrhagic stroke (relative reduction, 30%; P = .002). Death rates were also significantly lower (RR, 0.88; 95% CI, 0.82-0.96; P = .003), with larger effects on stroke-related deaths (relative reduction 21%; P = .01). No significant difference was observed for hyperkalemia (RR, 1.01; 95% CI, 0.74-1.38; P = .96).
Conclusions and relevance: Results of this cluster trial demonstrate that salt substitution was safe, along with reduced risks of stroke recurrence and death, which underscores large health gains from scaling up this low-cost intervention among patients with stroke.
Trial registration: ClinicalTrials.gov Identifier: NCT02092090.
Conflict of interest statement
Comment on
-
Dietary Sodium- and Potassium-Enriched Salt Substitutes-The Tipping Point?JAMA Cardiol. 2025 Apr 1;10(4):309-311. doi: 10.1001/jamacardio.2024.5430. JAMA Cardiol. 2025. PMID: 39908031 No abstract available.
Similar articles
-
Effect of sodium-reduced potassium-enriched salt substitutes on stomach cancer: the Salt Substitute and Stroke Study (SSaSS).BMC Med. 2025 Apr 23;23(1):236. doi: 10.1186/s12916-025-04068-0. BMC Med. 2025. PMID: 40264179 Free PMC article. Clinical Trial.
-
Effect of Salt Substitution on Cardiovascular Events and Death.N Engl J Med. 2021 Sep 16;385(12):1067-1077. doi: 10.1056/NEJMoa2105675. Epub 2021 Aug 29. N Engl J Med. 2021. PMID: 34459569 Clinical Trial.
-
Effect of salt substitution on fracture-a secondary analysis of the Salt Substitute and Stroke Study (SSaSS).BMC Med. 2024 Sep 4;22(1):366. doi: 10.1186/s12916-024-03586-7. BMC Med. 2024. PMID: 39232779 Free PMC article. Clinical Trial.
-
Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis.Heart. 2022 Sep 26;108(20):1608-1615. doi: 10.1136/heartjnl-2022-321332. Heart. 2022. PMID: 35945000
-
Effect of salt reduction interventions in lowering blood pressure in Chinese populations: a systematic review and meta-analysis of randomised controlled trials.BMJ Open. 2020 Feb 17;10(2):e032941. doi: 10.1136/bmjopen-2019-032941. BMJ Open. 2020. PMID: 32071177 Free PMC article.
References
-
- Chen Y, Wright N, Guo Y, et al. ; China Kadoorie Biobank Collaborative Group . Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0.5 million Chinese adults. Lancet Glob Health. 2020;8(4):e580-e590. doi:10.1016/S2214-109X(20)30069-3 - DOI - PMC - PubMed
-
- Kleindorfer DO, Towfighi A, Chaturvedi S, et al. . 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364-e467. doi:10.1161/STR.0000000000000375 - DOI - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical